TriSalus Life Sciences
TLSI
TLSI
72 hedge funds and large institutions have $225M invested in TriSalus Life Sciences in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0.01% less ownership
Funds ownership: 93.66% → 93.64% (-0.01%)
Holders
72
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$6.4M | |
| 2 | +$4.51M | |
| 3 | +$2.63M | |
| 4 |
Jane Street
New York
|
+$2.02M |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$1.88M |
Top Sellers
| 1 | -$6.19M | |
| 2 | -$4.92M | |
| 3 | -$4.08M | |
| 4 |
Millennium Management
New York
|
-$3.53M |
| 5 |
Goldman Sachs
New York
|
-$3.03M |